Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Design Therapeutics
89
Design Therapeutics
Technology
Biotechnology
Life Sciences
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
Suggest edits
Raised
$45M
Follow us
Companies in the same industry
TELA Bio
Tango Therapeutics
Green Goods Invest
CC Diagnostics
ALPS Global Holding
Inospin.com (Biowebspin SA)
PharmaVOICE
Ouro_botics
Recombinetics
Palvella Therapeutics
Overview
Funding
1
Add info
Latest funding
$45,000,000
Venture capital (Series A) - 2020
SR One
Cormorant Asset Management
Quan Capital
+1
Team Size
1–10
Employees
I work here
Pulse 2.0
Design Therapeutics Stock (DSGN): $10 Price Target From Goldman Sachs
$45,000,000
Venture capital (Series A)
FinSMEs
Design Therapeutics Raises $45M in Series A Funding
